NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $22,035,000 | -5.8% | 1,825,600 | 0.0% | 1.12% | +2.0% |
| Q2 2014 | $23,404,000 | +5.8% | 1,825,600 | 0.0% | 1.10% | +1.1% |
| Q1 2014 | $22,126,000 | +6.8% | 1,825,600 | 0.0% | 1.09% | +8.5% |
| Q4 2013 | $20,721,000 | +8.6% | 1,825,600 | 0.0% | 1.00% | +32.4% |
| Q3 2013 | $19,078,000 | -9.5% | 1,825,600 | 0.0% | 0.76% | -19.7% |
| Q2 2013 | $21,086,000 | – | 1,825,600 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |